Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone versus dexamethasone in pump prime solution during CABG
IRCT20170620034666N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in coronary arteriosclerosis comparing Methylprednisolone in prime solution with Dexamethasone in prime solution (2 arms). Primary endpoints: Duration of mechanical ventilation, Days of hospitalization and 3 more. Started Jul 2019; status: completed.
02
Drugs
methylprednisolonedexamethasone
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20170620034666N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170620034666N2.